513 related articles for article (PubMed ID: 33490935)
1. (
Molina-Molina E; Shanmugam H; Di Ciaula A; Grattagliano I; Di Palo DM; Palmieri VO; Portincasa P
JHEP Rep; 2021 Feb; 3(1):100203. PubMed ID: 33490935
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver.
Di Ciaula A; Carbone F; Shanmugham H; Molina-Molina E; Bonfrate L; Ministrini S; Montecucco F; Portincasa P
Eur J Intern Med; 2021 Jul; 89():56-64. PubMed ID: 33867228
[TBL] [Abstract][Full Text] [Related]
3. Volatomic analysis identifies compounds that can stratify non-alcoholic fatty liver disease.
Sinha R; Lockman KA; Homer NZM; Bower E; Brinkman P; Knobel HH; Fallowfield JA; Jaap AJ; Hayes PC; Plevris JN
JHEP Rep; 2020 Oct; 2(5):100137. PubMed ID: 32775974
[TBL] [Abstract][Full Text] [Related]
4. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
[TBL] [Abstract][Full Text] [Related]
5. Liver fat accumulation more than fibrosis causes early liver dynamic dysfunction in patients with non-alcoholic fatty liver disease.
Di Ciaula A; Shanmugam H; Ribeiro R; Pina A; Andrade R; Bonfrate L; Raposo JF; Macedo MP; Portincasa P
Eur J Intern Med; 2023 Jan; 107():52-59. PubMed ID: 36344354
[TBL] [Abstract][Full Text] [Related]
6. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
McGlinchey AJ; Govaere O; Geng D; Ratziu V; Allison M; Bousier J; Petta S; de Oliviera C; Bugianesi E; Schattenberg JM; Daly AK; Hyötyläinen T; Anstee QM; Orešič M
JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
[TBL] [Abstract][Full Text] [Related]
8. Effects of MBOAT7 polymorphism and steatosis on liver function assessed by methacetin breath test.
Di Ciaula A; Bonfrate L; Shanmugam H; Weber SN; Krawczyk M; Portincasa P
Eur J Clin Invest; 2023 Aug; 53(8):e14003. PubMed ID: 37029745
[TBL] [Abstract][Full Text] [Related]
9. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
10. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
Ooi GJ; Meikle PJ; Huynh K; Earnest A; Roberts SK; Kemp W; Parker BL; Brown W; Burton P; Watt MJ
J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease.
Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S
JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831
[TBL] [Abstract][Full Text] [Related]
12. Value of Liver Function Tests in Cirrhosis.
Sharma P
J Clin Exp Hepatol; 2022; 12(3):948-964. PubMed ID: 35677506
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests.
Di Ciaula A; Calamita G; Shanmugam H; Khalil M; Bonfrate L; Wang DQ; Baffy G; Portincasa P
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299321
[TBL] [Abstract][Full Text] [Related]
14. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis.
Portincasa P; Grattagliano I; Lauterburg BH; Palmieri VO; Palasciano G; Stellaard F
Clin Sci (Lond); 2006 Aug; 111(2):135-43. PubMed ID: 16603025
[TBL] [Abstract][Full Text] [Related]
15. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
[No Abstract] [Full Text] [Related]
16. Higher phenolic acid intake independently associates with lower prevalence of insulin resistance and non-alcoholic fatty liver disease.
Salomone F; Ivancovsky-Wajcman D; Fliss-Isakov N; Webb M; Grosso G; Godos J; Galvano F; Shibolet O; Kariv R; Zelber-Sagi S
JHEP Rep; 2020 Apr; 2(2):100069. PubMed ID: 32195455
[TBL] [Abstract][Full Text] [Related]
17. Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial.
Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagström H; Stål P
JHEP Rep; 2021 Jun; 3(3):100256. PubMed ID: 33898960
[TBL] [Abstract][Full Text] [Related]
18. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients.
Lee YH; Kim KJ; Yoo ME; Kim G; Yoon HJ; Jo K; Youn JC; Yun M; Park JY; Shim CY; Lee BW; Kang SM; Ha JW; Cha BS; Kang ES
J Hepatol; 2018 Apr; 68(4):764-772. PubMed ID: 29175242
[TBL] [Abstract][Full Text] [Related]
19. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
[TBL] [Abstract][Full Text] [Related]
20. Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis.
Le TA; Loomba R
J Clin Exp Hepatol; 2012 Jun; 2(2):156-73. PubMed ID: 25755424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
